Literature DB >> 3687438

Astrocytes in the postnatal central nervous system. From birth to 14 years of age. An immunohistochemical study on paraffin-embedded material.

E Reske-Nielsen1, M Gregersen, E Lund.   

Abstract

The postnatal development of the fibrillary astrocyte in 25 children without any anamnestic or post mortem signs of disease were studied. The investigation was performed on basis of the immunoperoxidase method for glial fibrillary acidic protein (GFAP). The supporting function of the external glial limiting membrane, the glial vascular limiting membrane and the metabolic role of the astrocytes are stressed. During the postnatal myelination of the white matter the immature astrocyte changed into the mature form and a dense fibrous network developed. The radially oriented glial processes of the Bergmann astrocytes of the cerebellum guided the fetal external granular cells during the migration. In the brainstem we found minor variations of the dense fibrous astrocytic network both in children dead after accidents and in sudden infant death syndrome. These findings presumably demonstrate a normal pattern.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3687438

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Immunol Scand A        ISSN: 0108-0164


  3 in total

1.  Binge-like postnatal alcohol exposure triggers cortical gliogenesis in adolescent rats.

Authors:  Jennifer L Helfer; Lyngine H Calizo; Willie K Dong; Charles R Goodlett; William T Greenough; Anna Y Klintsova
Journal:  J Comp Neurol       Date:  2009-05-20       Impact factor: 3.215

2.  Lafora's disease and brain calcifications.

Authors:  S Oster; E Reske-Nielsen; I Bruun
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

3.  Beta-endorphin immunoreactivity in spinal fluid and hypoxanthine in vitreous humour related to brain stem gliosis in sudden infant death victims.

Authors:  H Storm; T O Rognum; O D Saugstad; K Skullerud; K L Reichelt
Journal:  Eur J Pediatr       Date:  1994-09       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.